| 1 |
Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z, Qiao B, Wang C. Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther 2023;8:124. [PMID: 36922504 DOI: 10.1038/s41392-023-01382-y] [Reference Citation Analysis]
|
| 2 |
Mathew B, Acha LG, Torres LA, Huang CC, Liu A, Kalinin S, Leung K, Dai Y, Feinstein DL, Ravindran S, Roth S. MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: Engineered extracellular vesiclesand retinal ischemia. Acta Biomater 2023;158:782-97. [PMID: 36638942 DOI: 10.1016/j.actbio.2023.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Nonaka T. Application of engineered extracellular vesicles to overcome drug resistance in cancer. Front Oncol 2022;12:1070479. [PMID: 36591444 DOI: 10.3389/fonc.2022.1070479] [Reference Citation Analysis]
|
| 4 |
Ansari A, Hussain A, Wadekar R, Altamimi MA, Malik A, Mujtaba MA, Ansari MY, Siddique MUM, Goyal SN. Nanovesicles based drug targeting to control tumor growth and metastasis. Advances in Cancer Biology - Metastasis 2022. [DOI: 10.1016/j.adcanc.2022.100083] [Reference Citation Analysis]
|
| 5 |
Tian BW, Han CL, Dong ZR, Tan SY, Wang DX, Li T. Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:4036. [PMID: 36011030 DOI: 10.3390/cancers14164036] [Reference Citation Analysis]
|
| 6 |
Parayath NN, Gandham SK, Amiji MM. Tumor-targeted miRNA nanomedicine for overcoming challenges in immunity and therapeutic resistance. Nanomedicine (Lond) 2022;17:1355-73. [PMID: 36255330 DOI: 10.2217/nnm-2022-0130] [Reference Citation Analysis]
|
| 7 |
Psaraki A, Ntari L, Karakostas C, Korrou-Karava D, Roubelakis MG. Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases. Hepatology 2022;75:1590-603. [PMID: 34449901 DOI: 10.1002/hep.32129] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 8 |
Ghidini M, Silva SG, Evangelista J, do Vale MLC, Farooqi AA, Pinheiro M. Nanomedicine for the Delivery of RNA in Cancer. Cancers 2022;14:2677. [DOI: 10.3390/cancers14112677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Deng L, Liang P, Cui H. Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy? Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.03.007] [Reference Citation Analysis]
|
| 10 |
Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 2022:S0168-9525(22)00018-X. [PMID: 35303998 DOI: 10.1016/j.tig.2022.02.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 11 |
Ma H, Weng F, Wang L, Tong X, Yao Y, Li H. Extracellular vesicle-mediated delivery of miR-127-3p inhibits the proliferation and invasion of choriocarcinoma cells by targeting ITGA6. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Tominaga N. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. Cancers (Basel) 2021;13:6303. [PMID: 34944923 DOI: 10.3390/cancers13246303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Limongi T, Susa F, Marini M, Allione M, Torre B, Pisano R, di Fabrizio E. Lipid-Based Nanovesicular Drug Delivery Systems. Nanomaterials (Basel) 2021;11:3391. [PMID: 34947740 DOI: 10.3390/nano11123391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Aneesh A, Liu A, Moss HE, Feinstein D, Ravindran S, Mathew B, Roth S. Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 2021;12:594. [PMID: 34863294 DOI: 10.1186/s13287-021-02645-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Nimitrungtawee N, Inmutto N, Chattipakorn SC, Chattipakorn N. Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma. Cancer Med 2021. [PMID: 34708589 DOI: 10.1002/cam4.4370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Kostallari E, Valainathan S, Biquard L, Shah VH, Rautou PE. Role of extracellular vesicles in liver diseases and their therapeutic potential. Adv Drug Deliv Rev 2021;175:113816. [PMID: 34087329 DOI: 10.1016/j.addr.2021.05.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 17 |
Magenta A, Florio MC, Ruggeri M, Furgiuele S. Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review). Int J Mol Med 2021;48:173. [PMID: 34278463 DOI: 10.3892/ijmm.2021.5006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 18 |
Simionescu N, Zonda R, Petrovici AR, Georgescu A. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. Pharmaceutics 2021;13:988. [PMID: 34210109 DOI: 10.3390/pharmaceutics13070988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Roy B, Ghose S, Biswas S. Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma. Semin Cell Dev Biol 2021:S1084-9521(21)00079-3. [PMID: 33926792 DOI: 10.1016/j.semcdb.2021.04.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 20 |
Yang Y, Mao F, Guo L, Shi J, Wu M, Cheng S, Guo W. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP. Dig Liver Dis 2021;53:474-85. [PMID: 33563583 DOI: 10.1016/j.dld.2021.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: A signature for cancer progression. Biomed Pharmacother 2021;138:111528. [PMID: 33770669 DOI: 10.1016/j.biopha.2021.111528] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 22 |
Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, Taheri M. MicroRNA signature in liver cancer. Pathol Res Pract 2021;219:153369. [PMID: 33626406 DOI: 10.1016/j.prp.2021.153369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 23 |
Han Y, Jones TW, Dutta S, Zhu Y, Wang X, Narayanan SP, Fagan SC, Zhang D. Overview and Update on Methods for Cargo Loading into Extracellular Vesicles. Processes (Basel) 2021;9:356. [PMID: 33954091 DOI: 10.3390/pr9020356] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 24 |
Semaan L, Zeng Q, Lu Y, Zhang Y, Zreik MM, Chamseddine MB, Chopp M, Zhang ZG, Moonka D. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs. Oncotarget 2021;12:185-98. [PMID: 33613846 DOI: 10.18632/oncotarget.27879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Li L, He K, Chen S, Wei W, Tian Z, Tang Y, Xiao C, Xiang G. Circ_0001175 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis by Regulating miR-130a-5p. Onco Targets Ther 2020;13:13315-27. [PMID: 33408482 DOI: 10.2147/OTT.S262408] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Zhang X, Yang Y, Yang Y, Chen H, Tu H, Li J. Exosomes from Bone Marrow Microenvironment-Derived Mesenchymal Stem Cells Affect CML Cells Growth and Promote Drug Resistance to Tyrosine Kinase Inhibitors. Stem Cells Int 2020;2020:8890201. [PMID: 33414831 DOI: 10.1155/2020/8890201] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 27 |
Ailuno G, Baldassari S, Lai F, Florio T, Caviglioli G. Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research. Cells 2020;9:E2569. [PMID: 33271820 DOI: 10.3390/cells9122569] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 28 |
Zheng Z, Wen Y, Nie K, Tang S, Chen X, Lan S, Pan J, Jiang K, Jiang X, Liu P, Yan Y, Liu F, Liu Y, Li P. Construction of a 13-microRNA-based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma. Hepatol Res 2020;50:1151-63. [PMID: 32567216 DOI: 10.1111/hepr.13538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 29 |
Fu S, Wang Y, Xia X, Zheng JC. Exosome engineering: Current progress in cargo loading and targeted delivery. NanoImpact 2020;20:100261. [DOI: 10.1016/j.impact.2020.100261] [Cited by in Crossref: 94] [Cited by in F6Publishing: 44] [Article Influence: 31.3] [Reference Citation Analysis]
|
| 30 |
Huyan T, Li H, Peng H, Chen J, Yang R, Zhang W, Li Q. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements. Int J Nanomedicine 2020;15:6485-502. [PMID: 32922012 DOI: 10.2147/IJN.S238099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
